Physician's Weekly

JUNE 18, 2025

WEDNESDAY, June 18, 2025 (HealthDay News) — Drugmaker Eli Lilly plans to buy Verve Therapeutics , a gene-editing startup, for about $1 billion upfront. Verve is developing a new class of gene-editing drugs that could be given just once to treat chronic conditions. The deal, announced June 17, includes a cash offer of $10.50

Chronic Condition 52

Chronic Condition Diabetes Clinic Patients 52

GeriPal

JANUARY 23, 2025

In our third segment, we explore Amy Linskys study that examined the effect of patient-directed educational materials on clinician deprescribing of potentially low-benefit or high-risk medications, such as proton pump inhibitors, high-dose gabapentin, or risky diabetes medications. Alex 00:07 We have a full house to talk about deprescribing.

Specialization 119

Specialization IT Patient-Centered Medical 119

GeriPal

JUNE 19, 2025

Eric and I remember him from that time and he’s now at the University of Nevada, Las Vegas, where he is associate professor in the department of social and behavioral health. Jace, welcome to the GeriPal Podcast. Jace 00:37 Thank you so much, Alex and Eric, it’s nice to be here with you. Eric 01:21 Why’d you choose this song?

Individual 81

Individual Community IT Chronic Condition 81

Doctor On Demand

APRIL 28, 2025

In fact, most sore throat symptoms resolve in three days for 60-70% of patients, according to March 2025 UpToDate, an evidence-based clinical decision support system used by healthcare professionals. Urgent care clinics provide quick diagnoses and treatments, including antibiotics if needed.

ER 52

ER Telehealth Primary Care Doctor Appointment 52